1051 related articles for article (PubMed ID: 27220757)
21. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
Staeck A; Khadzhynov D; Kleinsteuber A; Lehner L; Duerr M; Budde K; Lachmann N; Halleck F; Staeck O
Transpl Immunol; 2020 Dec; 63():101333. PubMed ID: 32919027
[TBL] [Abstract][Full Text] [Related]
22. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
Okabe Y; Noguchi H; Miyamoto K; Kaku K; Tsuchimoto A; Masutani K; Nakamura M
Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation.
Jung HY; Kim SH; Seo MY; Cho SY; Yang Y; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
J Korean Med Sci; 2018 Aug; 33(34):e217. PubMed ID: 30127706
[TBL] [Abstract][Full Text] [Related]
24. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of two methods to detect donor-specific anti-HLA antibodies after kidney transplant.
Gil BC; Kulzer ASS; de Moraes P; Toresan R; da Rosa Vicari A; Dos Santos Fagundes I; Merzoni J; Ewald GM; Cardone JM; Silva FG; Manfro RC; Jobim LF
Transpl Immunol; 2018 Aug; 49():7-11. PubMed ID: 29577967
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
27. Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation.
den Dulk AC; Shi X; Verhoeven CJ; Dubbeld J; Claas FHJ; Wolterbeek R; Brand-Schaaf SH; Verspaget HW; Sarasqueta AF; van der Laan LJW; Metselaar HJ; van Hoek B; Kwekkeboom J; Roelen DL
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29193362
[TBL] [Abstract][Full Text] [Related]
28. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.
Friebus-Kardash J; Wilde B; Keles D; Heinold A; Kribben A; Witzke O; Heinemann FM; Eisenberger U
Transpl Immunol; 2018 Apr; 47():10-17. PubMed ID: 29277566
[TBL] [Abstract][Full Text] [Related]
29. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
30. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
32. Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Deltombe C; Gillaizeau F; Anglicheau D; Morelon E; Trébern-Launay K; Le Borgne F; Rimbert M; Guérif P; Malard-Castagnet S; Foucher Y; Giral M
Transpl Int; 2017 Nov; 30(11):1150-1160. PubMed ID: 28686316
[TBL] [Abstract][Full Text] [Related]
33. De novo donor specific antibodies and patient outcomes in renal transplantation.
DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA
Clin Transpl; 2011; ():351-8. PubMed ID: 22755430
[TBL] [Abstract][Full Text] [Related]
34. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ
Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
[TBL] [Abstract][Full Text] [Related]
35. De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes.
Brooks AM; Carter V; Liew A; Marshall H; Aldibbiat A; Sheerin NS; Manas DM; White SA; Shaw JA
Am J Transplant; 2015 Dec; 15(12):3239-46. PubMed ID: 26227015
[TBL] [Abstract][Full Text] [Related]
36. Impact of persistent preformed and de novo donor-specific antibodies detected at 1 year after kidney transplantation on long-term graft survival in Japan: a retrospective study.
Fujiyama N; Satoh S; Saito M; Numakura K; Inoue T; Yamamoto R; Saito T; Kanda S; Narita S; Mitobe Y; Habuchi T
Clin Exp Nephrol; 2019 Dec; 23(12):1398-1406. PubMed ID: 31493185
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and impact of HLA and MICA allele mismatching on donor-specific antibodies induction in kidney transplant rejection.
Romphruk AV; Simtong P; Suntornnipat J; Sudwilai Y; Cheunta S; Chan-On C; Leelayuwat C
Nephrology (Carlton); 2021 Oct; 26(10):833-841. PubMed ID: 34197005
[TBL] [Abstract][Full Text] [Related]
38. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients.
Lee H; Lee H; Eum SH; Ko EJ; Min JW; Oh EJ; Yang CW; Chung BH
Ann Lab Med; 2023 Jul; 43(4):364-374. PubMed ID: 36843405
[TBL] [Abstract][Full Text] [Related]
39. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
[TBL] [Abstract][Full Text] [Related]
40. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
